| Microbiota in health and diseases K Hou, ZX Wu, XY Chen, JQ Wang, D Zhang, C Xiao, D Zhu, JB Koya, ... Signal transduction and targeted therapy 7 (1), 1-28, 2022 | 735 | 2022 |
| The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer L Zhang, Y Li, Q Wang, Z Chen, X Li, Z Wu, C Hu, D Liao, W Zhang, ... Molecular Cancer 19, 1-18, 2020 | 88 | 2020 |
| Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications H Song, D Liu, S Dong, L Zeng, Z Wu, P Zhao, L Zhang, ZS Chen, C Zou Signal transduction and targeted therapy 5 (1), 193, 2020 | 83 | 2020 |
| Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19 ZN Lei, ZX Wu, S Dong, DH Yang, L Zhang, Z Ke, C Zou, ZS Chen Pharmacology & Therapeutics 216, 107672, 2020 | 80 | 2020 |
| ATP‐binding cassette (ABC) transporters in cancer: A review of recent updates JQ Wang, ZX Wu, Y Yang, QX Teng, YD Li, ZN Lei, KA Jani, N Kaushal, ... Journal of Evidence‐Based Medicine 14 (3), 232-256, 2021 | 73 | 2021 |
| Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function L Gao, ZX Wu, YG Assaraf, ZS Chen, L Wang Drug Resistance Updates 57, 100770, 2021 | 68 | 2021 |
| Nano-drug delivery systems entrapping natural bioactive compounds for cancer: recent progress and future challenges VP Chavda, AB Patel, KJ Mistry, SF Suthar, ZX Wu, ZS Chen, K Hou Frontiers in oncology 12, 867655, 2022 | 59 | 2022 |
| Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells ZX Wu, QX Teng, CY Cai, JQ Wang, ZN Lei, Y Yang, YF Fan, JY Zhang, ... Biochemical pharmacology 166, 120-127, 2019 | 57 | 2019 |
| Targeting HNRNPU to overcome cisplatin resistance in bladder cancer Z Shi, L Hao, X Han, ZX Wu, K Pang, Y Dong, J Qin, G Wang, X Zhang, ... Molecular Cancer 21 (1), 37, 2022 | 47 | 2022 |
| Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies ZD Shi, K Pang, ZX Wu, Y Dong, L Hao, JX Qin, W Wang, ZS Chen, ... Signal Transduction and Targeted Therapy 8 (1), 113, 2023 | 46 | 2023 |
| Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression Z Pan, K Wang, X Wang, Z Jia, Y Yang, Y Duan, L Huang, ZX Wu, J Zhang, ... Molecular cancer 21 (1), 77, 2022 | 45 | 2022 |
| Tivantinib, A c-met inhibitor in clinical trials, is susceptible to ABCG2-mediated drug resistance ZX Wu, Y Yang, QX Teng, JQ Wang, ZN Lei, JQ Wang, S Lusvarghi, ... Cancers 12 (1), 186, 2020 | 39 | 2020 |
| Overexpression of ABCB1 transporter confers resistance to mTOR inhibitor WYE-354 in cancer cells J Wang, DH Yang, Y Yang, JQ Wang, CY Cai, ZN Lei, QX Teng, ZX Wu, ... International journal of molecular sciences 21 (4), 1387, 2020 | 35 | 2020 |
| Erdafitinib antagonizes ABCB1-mediated multidrug resistance in cancer cells W Feng, M Zhang, ZX Wu, JQ Wang, XD Dong, Y Yang, QX Teng, ... Frontiers in oncology 10, 955, 2020 | 34 | 2020 |
| Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro Y Yang, N Ji, QX Teng, CY Cai, JQ Wang, ZX Wu, ZN Lei, S Lusvarghi, ... Frontiers in oncology 10, 700, 2020 | 34 | 2020 |
| Midostaurin Reverses ABCB1-Mediated Multidrug Resistance, an in vitro Study N Ji, Y Yang, CY Cai, JQ Wang, ZN Lei, ZX Wu, Q Cui, DH Yang, ZS Chen, ... Frontiers in oncology 9, 514, 2019 | 32 | 2019 |
| Dual TTK/CLK2 inhibitor, CC‐671, selectively antagonizes ABCG2‐mediated multidrug resistance in lung cancer cells ZX Wu, Y Yang, G Wang, JQ Wang, QX Teng, L Sun, ZN Lei, L Lin, ... Cancer Science 111 (8), 2872-2882, 2020 | 30 | 2020 |
| Role of protein phosphorylation in cell signaling, disease, and the intervention therapy K Pang, W Wang, JX Qin, ZD Shi, L Hao, YY Ma, H Xu, ZX Wu, D Pan, ... MedComm 3 (4), e175, 2022 | 28 | 2022 |
| Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor Y Yang, N Ji, CY Cai, JQ Wang, ZN Lei, QX Teng, ZX Wu, Q Cui, Y Pan, ... Cancer Communications 40 (7), 285-300, 2020 | 26 | 2020 |
| M3814, a DNA-PK inhibitor, modulates ABCG2-mediated multidrug resistance in lung cancer cells ZX Wu, Z Peng, Y Yang, JQ Wang, QX Teng, ZN Lei, YG Fu, K Patel, L Liu, ... Frontiers in Oncology 10, 674, 2020 | 26 | 2020 |
